90 related articles for article (PubMed ID: 7066260)
21. Immune complexes and human neoplasia.
Salinas FA; Wee KH; Silver HK
Biomed Pharmacother; 1983; 37(5):211-8. PubMed ID: 6362736
[TBL] [Abstract][Full Text] [Related]
22. Soluble interleukin-2 receptor alpha is elevated in sera of patients with benign ovarian neoplasms and epithelial ovarian cancer.
Hurteau JA; Woolas RP; Jacobs IJ; Oram DC; Kurman CC; Rubin LA; Nelson DL; Berchuck A; Bast RC; Mills GB
Cancer; 1995 Nov; 76(9):1615-20. PubMed ID: 8635066
[TBL] [Abstract][Full Text] [Related]
23. Plasmapheresis in rapidly progressive Henoch-Schoenlein glomerulonephritis and the effect on circulating IgA immune complexes.
Kauffmann RH; Houwert DA
Clin Nephrol; 1981 Sep; 16(3):155-60. PubMed ID: 7296974
[TBL] [Abstract][Full Text] [Related]
24. Circulating immune complexes in breast and lung cancer, before and after chemotherapy.
García MS; Barañao RI; Fernández O; Bordenave H; Rumi LS
Allergol Immunopathol (Madr); 1987; 15(1):15-8. PubMed ID: 3604838
[TBL] [Abstract][Full Text] [Related]
25. A prospective study of circulating immune complexes in patients with breast cancer.
Bukh A; Aguado MT; Krarup N; Poulsen HS; Nordentoft AM; Møller NP
Int J Cancer; 1988 Mar; 41(3):364-70. PubMed ID: 3257943
[TBL] [Abstract][Full Text] [Related]
26. Bacillus Calmette-Guérin immunotherapy in ovarian cancer.
Pattillo RA; Komaki R; Reynolds M; Robles J
J Reprod Med; 1988 Jan; 33(1):41-5. PubMed ID: 3351805
[TBL] [Abstract][Full Text] [Related]
27. Potentiation of a p53-SLP vaccine by cyclophosphamide in ovarian cancer: a single-arm phase II study.
Vermeij R; Leffers N; Hoogeboom BN; Hamming IL; Wolf R; Reyners AK; Molmans BH; Hollema H; Bart J; Drijfhout JW; Oostendorp J; van der Zee AG; Melief CJ; van der Burg SH; Daemen T; Nijman HW
Int J Cancer; 2012 Sep; 131(5):E670-80. PubMed ID: 22139992
[TBL] [Abstract][Full Text] [Related]
28. Primary lung cancer. A controlled study of preoperative and postoperative levels of circulating immune complexes.
Bukh A; Aguado MT; Kimose HH; Mouritzen C; Møoller NP
Cancer; 1988 May; 61(10):2033-41. PubMed ID: 3258788
[TBL] [Abstract][Full Text] [Related]
29. Circulating immune complexes detected by 125I-Clq deviation test in sera of cancer patients.
Teshima H; Wanebo H; Pinsky C; Day NK
J Clin Invest; 1977 Jun; 59(6):1134-42. PubMed ID: 325016
[TBL] [Abstract][Full Text] [Related]
30. Identification of material with paternal HLA antigen immunoreactivity from purported circulating immune complexes in patients with gestational trophoblastic neoplasia.
Lahey SJ; Steele G; Berkowitz R; Rodrick ML; Ross DS; Goldstein DP; Zamcheck N; Wilson RE; Deasy JM
J Natl Cancer Inst; 1984 May; 72(5):983-90. PubMed ID: 6325794
[TBL] [Abstract][Full Text] [Related]
31. [Circulating immune complex of ovarian epithelial carcinoma and its clinical use].
Cui H; Qian HN
Zhonghua Fu Chan Ke Za Zhi; 1987 Jul; 22(4):223-5, 253-4. PubMed ID: 3665670
[No Abstract] [Full Text] [Related]
32. Comparison of different assays for circulating immune complexes in age matched vasectomized and non-vasectomized men.
Witkin SS; Brandslund I; Svehag SE; Linnet L; møller NP
J Clin Lab Immunol; 1983 Apr; 10(4):193-7. PubMed ID: 6602887
[TBL] [Abstract][Full Text] [Related]
33. Analysis of antigen involved in circulating immune complexes in patients with idiopathic thrombocytopenic purpura.
Kurata Y; Hayashi S; Aochi H; Nagamine K; Oshida M; Mizutani H; Tomiyama Y; Tsubakio T; Yonezawa T; Tarui S
Clin Exp Immunol; 1987 Feb; 67(2):293-9. PubMed ID: 3608226
[TBL] [Abstract][Full Text] [Related]
34. A comparison of circulating immune complexes, pregnancy associated beta 1-macroglobulin and galactosyltransferase as tumour markers for ovarian cancer.
Dodd J; Davey RA; McAdam A; Stimson WH; Fay R; Crandon AJ; Hicks L; Tyler JP; Hudson CN
Aust N Z J Obstet Gynaecol; 1986 Aug; 26(3):203-5. PubMed ID: 3101659
[TBL] [Abstract][Full Text] [Related]
35. Circulating immune complexes (CIC) as tumor marker in the follow-up of breast cancer.
Neri B; Comparini T; Ciatto S; Cataliotti L; Distante V; Bartalucci S
Cancer Detect Prev; 1985; 8(1-2):53-6. PubMed ID: 4064052
[TBL] [Abstract][Full Text] [Related]
36. Immune complexes in syphilis sera.
Wozniczko-Orlowska G; Milgrom F
J Immunol; 1981 Sep; 127(3):1048-51. PubMed ID: 7196425
[TBL] [Abstract][Full Text] [Related]
37. Circulating tumour markers in ovarian tumours.
von Schlippe M; Rustin GJ
Forum (Genova); 2000; 10(4):383-92. PubMed ID: 11535987
[TBL] [Abstract][Full Text] [Related]
38. Ovarian cancer: immunologic diagnosis and therapy.
Barber HR; Dorsett B
Contrib Gynecol Obstet; 1985; 14():176-84. PubMed ID: 3905251
[No Abstract] [Full Text] [Related]
39. Pre-operative and post-operative evaluation of circulating immune complexes in patients with gastric adenocarcinoma.
Siddiqi MA; Salahuddin M; Shah OJ; Wani NA
Asian Pac J Allergy Immunol; 1989 Dec; 7(2):95-8. PubMed ID: 2624669
[TBL] [Abstract][Full Text] [Related]
40. Circulating immune complexes in renal transplant patients.
Sølling J
Clin Nephrol; 1983 Jan; 19(1):11-6. PubMed ID: 6339128
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
